Get the Stockscreener App
2.09
1.46%
0.03
After Hours:
2.09
Apyx Medical Corp stock is traded at $2.09, with a volume of 36,763.
It is up +1.46% in the last 24 hours and down -7.11% over the past month.
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
See More
Previous Close:
$2.06
Open:
$2.14
24h Volume:
36,763
Relative Volume:
0.41
Market Cap:
$79.04M
Revenue:
$52.35M
Net Income/Loss:
$-18.71M
P/E Ratio:
-3.8704
EPS:
-0.54
Net Cash Flow:
$-5.78M
1W Performance:
-3.24%
1M Performance:
-7.11%
6M Performance:
+38.41%
1Y Performance:
+60.77%
1-Day Range:
$2.05
$2.1869
1-Week Range:
$1.82
$2.199
52-Week Range:
$0.7554
$2.73
Apyx Medical Corp Stock (APYX) Company Profile
Name
Apyx Medical Corp
Sector
Industry
Phone
(727) 384-2323
Address
5115 ULMERTON ROAD, CLEARWATER, FL
Compare APYX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
APYX
Apyx Medical Corp
|
2.09 | 80.93M | 52.35M | -18.71M | -5.78M | -0.54 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Apyx Medical Corp Stock (APYX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-17-24 | Initiated | BTIG Research | Neutral |
| Jul-14-23 | Initiated | Stephens | Overweight |
| May-20-22 | Initiated | Lake Street | Buy |
| Apr-02-19 | Reiterated | Dougherty & Company | Buy |
Apyx Medical Corp Stock (APYX) Latest News
Short interest data insights for Apyx Medical CorporationJuly 2025 Pullbacks & Capital Protection Trading Alerts - Newser
How moving averages guide Apyx Medical Corporation trading2025 Earnings Impact & Weekly High Potential Stock Alerts - Newser
Does Apyx Medical Corporation show high probability of rebound2025 Risk Factors & Low Drawdown Momentum Ideas - Newser
Predicting Apyx Medical Corporation trend using moving averages2025 Big Picture & Short-Term High Return Strategies - Newser
Detecting price anomalies in Apyx Medical Corporation with AI2025 Market Outlook & Smart Money Movement Tracker - Newser
What machine learning models say about Apyx Medical CorporationTrade Ideas & Expert Curated Trade Ideas - Newser
What MACD and RSI say about Apyx Medical Corporation2025 Big Picture & Verified Entry Point Signals - Newser
Identifying reversal signals in Apyx Medical CorporationMarket Growth Report & Safe Capital Growth Tips - Newser
Apyx Medical Corporation stock chart pattern explained2025 Volume Leaders & Intraday High Probability Setup Alerts - Newser
What institutional flow reveals about Apyx Medical Corporation2025 Geopolitical Influence & Community Consensus Trade Signals - Newser
Top chart patterns to watch in Apyx Medical CorporationJuly 2025 Setups & Detailed Earnings Play Strategies - Newser
Using R and stats models for Apyx Medical Corporation forecastingTrade Performance Summary & Target Return Focused Stock Picks - Newser
Backtesting results for Apyx Medical Corporation trading strategiesJuly 2025 Chart Watch & Free High Return Stock Watch Alerts - Newser
What to expect from Apyx Medical Corporation in the next 30 daysTrade Ideas & Daily Price Action Insights - Newser
Is Apyx Medical Corporation forming a bottoming base2025 Market Trends & Low Drawdown Trading Techniques - Newser
How sentiment analysis helps forecast Apyx Medical CorporationMarket Performance Report & Technical Pattern Recognition Alerts - Newser
Is Apyx Medical Corporation reversing from oversold territoryQuarterly Trade Summary & Weekly Chart Analysis and Trade Guides - Newser
Why Apyx Medical Corporation stock attracts strong analyst attentionWeekly Trading Summary & Weekly High Potential Stock Alerts - Newser
Will Apyx Medical Corporation continue its uptrendHistorical Volatility and Pattern Breakdown Analysis - Newser
Apyx Medical at Canaccord Genuity: Strategic Growth and Market Adaptation - Investing.com
Risk vs reward if holding onto Apyx Medical CorporationLow Risk Strategy with Smart Entry Zones - Newser
Real time social sentiment graph for Apyx Medical CorporationFree Smart Trend Trading with Weekly Signals - Newser
Apyx Medical Q2 Earnings Call: Optimism Amid Revenue Decline and OEM Segment Challenges - AInvest
Pattern recognition hints at Apyx Medical Corporation upsideFree Reliable Alerts for Daily Stock Movers - Newser
Does Apyx Medical Corporation stock pay reliable dividendsBuy Opportunity Forecast for Fast Traders - Newser
What indicators show strength in Apyx Medical CorporationBuy Alert Based on RSI and Volume - Newser
Apyx Medical Corporation stock momentum explainedLow Risk High Confidence Watchlist Builder - Newser
Apyx Medical 2025 Q2 Earnings Narrowed Losses with 43.2% Net Income Improvement - AInvest
BTIG Reiterates Hold Rating for Apyx Medical Amid Mixed Analyst Sentiment - AInvest
Apyx Medical Corp reports results for the quarter ended June 30Earnings Summary - TradingView
Apyx Medical earnings beat by $0.18, revenue fell short of estimates - Investing.com
Apyx Medical appoints two sales executives to support global expansion - Investing.com
Apyx Medical Expands Global Sales Leadership with Strategic Hires to Support AYON Launch and Accelerated Growth - GlobeNewswire
Apyx Medical Corporation Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
Apyx Medical Corporation Reports Second Quarter 2025 Financial Results - GlobeNewswire
Relative strength of Apyx Medical Corporation in sector analysisInvestment Position Summary with Timeframe Forecast - Newser
Apyx Medical Corp Stock (APYX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):